SCHEDULE 13G/A: Dimensional Fund Advisors Discloses 6.1% Stake in Utah Medical Products

Dimensional Fund Advisors LP has filed an amended Schedule 13G, reporting a 6.1% beneficial ownership stake in Utah Medical Products Inc. common stock as of June 30, 2025.

Summary

• Dimensional Fund Advisors LP reported beneficial ownership of 197,466 shares of Utah Medical Products Inc. Common Stock.
• This represents 6.1% of the total class of securities.
• Dimensional Fund Advisors LP holds sole voting power over 192,593 shares and sole dispositive power over 197,466 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previously reported beneficial ownership position.
• Dimensional Fund Advisors LP is an investment adviser registered under Section 203 of the Investment Advisors Act of 1940, acting on behalf of various investment companies, commingled funds, group trusts, and separate accounts.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that inherently suggests positive or negative sentiment regarding the issuer's performance or prospects. It is a neutral regulatory filing.

Positives

• A significant institutional investor, Dimensional Fund Advisors LP, maintains a substantial 6.1% stake in Utah Medical Products Inc., which could be interpreted as a sign of continued confidence in the company.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding Utah Medical Products Inc.'s future performance or outlook. It is a disclosure of current ownership.

Management Comments

• Dimensional Fund Advisors LP disclaims beneficial ownership of the securities, stating that all reported securities are owned by the Funds they advise.

Industry Context

Schedule 13G filings are routine disclosures by institutional investors who acquire more than 5% of a company's voting class of securities, but do not intend to influence or change control of the issuer. This filing indicates that Dimensional Fund Advisors LP, a significant investment adviser, holds a passive stake in Utah Medical Products Inc., a company operating in the medical products sector. Such filings provide transparency on significant ownership stakes in publicly traded companies.

Comparison to Industry Standards

• This filing is a standard regulatory disclosure for institutional investors crossing the 5% ownership threshold, consistent with SEC requirements.
• The 6.1% stake held by Dimensional Fund Advisors LP is a notable passive investment, typical for large index or quantitative fund managers who hold diversified portfolios including stakes in various companies like Utah Medical Products Inc.
• No specific comparable companies, projects, or performance results are mentioned in this filing for direct comparison.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional investor's stake, which can be viewed as a vote of confidence or simply a passive investment.
• Investment Community: Informs the market of a substantial passive ownership position by a major investment adviser.

Key Dates

Keywords

Utah Medical Products Inc., Dimensional Fund Advisors LP, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Investment Adviser